KLOW Stack

Product name

KLOW Stack

Form

Co-formulated blend: 1 lyophilised vial, 80mg total

Composition

GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg

Solubility

Bacteriostatic water

Storage

Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.

No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.

What is the KLOW Stack?

It is a co-formulated 80mg vial supplied as a reference material for non-clinical laboratory research: KPV (10mg), BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg), combined in one lyophilised unit. For laboratory research use only; not for human or veterinary use.

What is in the KLOW Stack?

One 80mg vial containing all four compounds: KPV (10mg), BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg). Each constituent links to its own product page for full chemistry and batch detail.

Is this the KLOW stack people search for?

Yes. KLOW is the established community shorthand for this four-compound grouping (the letters trace to the constituents). We use the nickname only to identify the vial; it is not a description of any effect.

What is the difference between KLOW and GLOW?

It is a difference of composition only. GLOW refers to the three-compound grouping of GHK-Cu, BPC-157 and TB-500. KLOW is the same three compounds with KPV (10mg) added, making an 80mg vial in total. Neither name describes an outcome; both are search shorthand for which reference compounds are included.

Is the KLOW Stack legal to buy in the UK?

The compounds are not controlled drugs under the Misuse of Drugs Act 1971 and are supplied as reference materials for in-vitro laboratory research only. They are not medicines, supplements or cosmetics, and the buyer is responsible for compliance with all applicable laws and institutional rules.

Is the KLOW Stack for human use?

No. The 80mg vial is strictly for in-vitro laboratory research. It is not a medicine, food, supplement or cosmetic and is not intended or supplied for human or veterinary use.

Have these compounds been shown to be safe or effective together in humans?

No. We make no such claim. Co-formulating the constituents into one vial is a supply and handling format only. No combined effect is claimed or implied, and combining them in a single vial does not produce any outcome. No human or veterinary use is intended or implied.

Why are these particular compounds combined in one vial?

Each of KPV, BPC-157, TB-500 and GHK-Cu has its own separate body of published non-clinical literature, set out on its own product page. They are co-formulated purely so a laboratory can source four reference compounds in a single 80mg vial in one order, not because grouping them produces any outcome. See each constituent product page for detail.

Is there a Certificate of Analysis for the 80mg vial?

Yes. Every compound in the vial is independently third-party tested, with purity assessed by HPLC at 99% or higher and identity confirmed against the expected mass. A Certificate of Analysis is available for every batch on our Certificates of Analysis page.

How is the KLOW Stack supplied and reconstituted?

As a single co-formulated 80mg lyophilised vial, so it is one reconstitution step rather than four. Laboratories typically reconstitute lyophilised reference peptides with a suitable laboratory solvent following their own standard operating procedures. Refer to each constituent product page for compound-specific handling.

How should the 80mg vial be stored?

Store the sealed lyophilised vial at -20C, kept dry and protected from light. Hold any reconstituted material at 2-8C. See each constituent product page for compound-specific storage detail.

Is the KLOW Stack despatched from the UK?

Yes. Orders are despatched from the UK. All items are supplied as reference materials for laboratory research use only; not for human or veterinary use.